The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Tick-Borne Infections in Turkey

Endemic and emerging tick-borne diseases in Turkey including CCHF, Lyme borreliosis, tularemia, rickettsioses, and Q fever

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Internal Medicine department. Book Appointment →

What is Tick-Borne Infections in Turkey?

Tick-borne infections represent a significant public health concern in Turkey, with diverse pathogens transmitted by various tick vectors across different geographic regions and ecological zones. Crimean-Congo hemorrhagic fever (CCHF) is endemic in central and eastern Anatolia (Tokat, Sivas, Yozgat, Kelkit valley among highest endemic areas), caused by Nairovirus from Bunyaviridae family, transmitted primarily by Hyalomma marginatum ticks but also by direct contact with infected animal blood/tissue and human-to-human nosocomial transmission. CCHF is characterized by abrupt fever, hemorrhagic manifestations (petechiae, ecchymoses, mucosal bleeding, gastrointestinal hemorrhage), thrombocytopenia, leukopenia, hepatic dysfunction, mortality 5-30% without treatment, ribavirin and supportive care reduce mortality, vaccine in development.

Lyme borreliosis is increasingly recognized in Turkey, particularly in Black Sea region forests and northern Anatolia, caused by Borrelia burgdorferi sensu lato (multiple genospecies including B. afzelii, B. garinii, B. burgdorferi sensu stricto), transmitted by Ixodes ricinus ticks. Clinical stages: early localized (erythema migrans, days to weeks after bite), early disseminated (multiple erythema migrans, neurologic involvement with cranial neuropathies, meningitis, radiculopathy, cardiac involvement with conduction blocks, weeks to months), late disseminated (chronic arthritis, acrodermatitis chronica atrophicans, neuroborreliosis with encephalopathy, months to years). Diagnosis: clinical with characteristic erythema migrans (>5 cm, expanding), serology with two-tier testing (ELISA followed by Western blot), PCR for selected specimens. Treatment: doxycycline 100 mg twice daily for 14-21 days for early Lyme, ceftriaxone 2 g daily for 14-28 days for neuroborreliosis or late stages, amoxicillin alternative for pregnant patients/children.

Tularemia (Francisella tularensis) is endemic in Turkey, with oropharyngeal form predominant (water-borne transmission from contaminated streams, wells in rural areas of Central Anatolia, Black Sea, Eastern Anatolia regions), but also tick-borne transmission via Dermacentor and Ixodes ticks causing ulceroglandular form. Multiple outbreaks documented with hundreds of cases. Treatment with streptomycin, gentamicin, or oral doxycycline/ciprofloxacin. Mediterranean spotted fever (Rickettsia conorii) endemic in southern coastal regions (Mediterranean, Aegean), transmitted by Rhipicephalus sanguineus (brown dog tick), characterized by fever, eschar at tick bite site (tache noire), rash including palms and soles, treated with doxycycline. Q fever (Coxiella burnetii) endemic in agricultural areas with livestock exposure (sheep, goats, cattle), presents with fever, pneumonia, hepatitis, with chronic form causing endocarditis, treated with doxycycline (acute) or doxycycline plus hydroxychloroquine (chronic). Tick-borne encephalitis (TBE) emerging in Black Sea forested regions. Babesiosis rare, Anaplasma phagocytophilum reported. Prevention: avoid tick-infested areas, protective clothing, DEET or permethrin repellents, prompt tick removal with fine-tipped tweezers (within 24-48 hours reduces transmission), surveillance programs in endemic regions, education of healthcare workers and public, vaccination for at-risk populations (CCHF vaccine being developed, TBE vaccine available).

Symptoms

Fever (most common, abrupt onset)
Headache
Myalgia and arthralgia
Fatigue and malaise
Petechiae and ecchymoses (CCHF)
Mucosal bleeding (CCHF)
Erythema migrans (Lyme borreliosis)
Annular expanding skin lesion
Multiple erythema migrans (disseminated)
Tick eschar (tache noire, MSF)
Maculopapular rash on trunk, palms, soles
Lymphadenopathy at bite site
Cervical lymphadenopathy (oropharyngeal tularemia)
Tonsillitis with pseudomembrane
Cranial nerve palsies (neuroborreliosis)
Cardiac conduction blocks (Lyme)
Meningitis (Lyme, TBE)
Encephalitis (TBE)
Hepatitis with elevated transaminases
Pneumonia (Q fever, tularemia)

Risk Factors

Tick exposure in endemic areas
Outdoor occupations (farmers, foresters, hunters)
Livestock workers (CCHF, Q fever)
Veterinarians (CCHF, Q fever)
Hiking and camping in forests
Spring and summer seasons (peak)
Travel to Anatolia (CCHF endemic)
Black Sea forests (Lyme, TBE)
Mediterranean coast (MSF)
Rural water sources (oropharyngeal tularemia)
Animal slaughter (CCHF)
Healthcare workers (CCHF nosocomial)
Direct animal blood/tissue contact
Tick attachment >24-48 hours
Failure to use repellents
Inadequate protective clothing
Pets (carry ticks home)
Hunting in endemic regions
Beekeeping (rare)
Children in forest areas

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Fever after tick bite
  • Erythema migrans rash
  • Annular expanding skin lesion
  • Tick bite with subsequent symptoms
  • Travel to CCHF endemic area with fever
  • Bleeding manifestations after tick exposure
  • Severe headache with fever
  • Neurological symptoms after tick bite
  • Cardiac symptoms after tick exposure
  • Cervical lymphadenopathy with fever
  • Tonsillitis with pseudomembrane
  • Persistent flu-like symptoms
  • Joint swelling and pain
  • Skin rash on palms and soles
  • Healthcare worker exposed to CCHF patient

Treatment Methods

01
Detailed history including tick exposure
02
Geographic and occupational history
03
Physical examination for tick attachment
04
Skin examination for erythema migrans, eschar
05
Lymph node evaluation
06
CBC with differential and platelet count
07
Comprehensive metabolic panel including liver enzymes
08
Coagulation panel (CCHF — DIC)
09
Specific serology by suspected pathogen
10
Lyme disease two-tier testing (ELISA + Western blot)
11
CCHF PCR for early diagnosis (RT-PCR)
12
Tularemia serology and PCR
13
Rickettsial serology
14
Q fever phase I and II antibodies
15
Blood cultures
16
CSF analysis if neurologic symptoms
17
ECG for cardiac involvement
18
Tick removal with fine-tipped tweezers
19
Tick identification and submission
20
Doxycycline 100 mg BID 14-21 days (Lyme, MSF)
21
Ceftriaxone 2 g daily 14-28 days (neuroborreliosis)
22
Streptomycin or gentamicin (tularemia)
23
Ribavirin for CCHF (controversial efficacy)
24
Supportive care for CCHF (hemorrhage management)
25
Doxycycline + hydroxychloroquine (chronic Q fever)
26
TBE: supportive care (no specific antiviral)
27
Hospital admission for severe disease
28
Isolation precautions for CCHF (contact, droplet)
29
Healthcare worker post-exposure follow-up
30
Notification to public health authorities
31
Surveillance and outbreak investigation
32
Tick avoidance education
33
DEET or picaridin repellents
34
Permethrin-treated clothing
35
Prompt tick removal (<24-48 hours)
36
Post-bite observation period
37
Vaccination updates (TBE if available)
38
Animal vector control programs
39
Public health surveillance
40
Multidisciplinary infectious disease consultation

Which Department to Visit?

You can visit our Enfeksiyon Hastalıkları department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Enfeksiyon Hastalıkları Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Flu (Influenza)

Enfeksiyon Hastalıkları

Influenza is a seasonal contagious respiratory disease caused by influenza viruses; it presents with high fever, muscle pain, and severe fatigue.

COVID-19

Enfeksiyon Hastalıkları

COVID-19 is a contagious disease caused by the SARS-CoV-2 coronavirus with a wide clinical spectrum ranging from asymptomatic to severe pneumonia.

Upper Respiratory Tract Infection

Enfeksiyon Hastalıkları

Upper respiratory tract infections are diseases that include common cold, pharyngitis, sinusitis, and laryngitis, often of viral origin and self-limited.

Urinary Tract Infection

Enfeksiyon Hastalıkları

Urinary tract infections are common bacterial infections most often caused by Escherichia coli, presenting with burning and frequent urination.

Hepatitis A (HAV)

Enfeksiyon Hastalıkları

Hepatitis A is an acute, self-limited liver infection transmitted via the fecal-oral route causing acute hepatitis without chronicity; supportive care suffices in most cases, while vaccination prevents outbreaks and post-exposure prophylaxis within 2 weeks is effective.

Hepatitis B

Enfeksiyon Hastalıkları

Hepatitis B is a contagious infection caused by HBV virus transmitted via blood, sexual intercourse, and mother-to-child, that can become chronic and progress to cirrhosis and liver cancer.

Hepatitis C

Enfeksiyon Hastalıkları

Hepatitis C is a liver disease caused by HCV virus transmitted mainly by blood; the rate of chronicity is high, but cure is possible with new antiviral drugs.

HIV/AIDS Information

Enfeksiyon Hastalıkları

HIV is a virus that targets the immune system; if untreated, it progresses to AIDS. With modern antiretroviral therapy, HIV-positive individuals can lead healthy, long lives.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.